High Levels of Alzheimer Beta-Amyloid Precursor Protein (APP) in Children With Severely Autistic Behavior and Aggression

Abstract

Autism is characterized by restricted, repetitive behaviors and impairment in socialization and communication. Although no neuropathologic substrate underlying autism has been found, the findings of brain overgrowth via neuroimaging studies and increased levels of brain-derived neurotrophic factor (BDNF) in neuropathologic and blood studies favor an anabolic state. We examined acetylcholinesterase, plasma neuronal proteins, secreted beta-amyloid precursor protein (APP), and amyloid-beta 40 and amyloid-beta 42 peptides in children with and without autism. Children with severe autism and aggression expressed secreted beta-amyloid precursor protein at two or more times the levels of children without autism and up to four times more than children with mild autism. There was a trend for children with autism to show higher levels of secreted beta-amyloid precursor protein and nonamyloidogenic secreted beta-amyloid precursor protein and lower levels of amyloid-beta 40 compared with controls. This favors an increased α-secretase pathway in autism (anabolic), opposite to what is seen in Alzheimer disease. Additionally, a complex relationship between age, acetylcholinesterase, and plasma neuronal markers was found. (J Child Neurol 2006;21:444—449; DOI 10.2310/7010.2006.00130).

Get full access to this article

View all access options for this article.

References

Sokol DK , Edwards-Brown M. : Neuroimaging in autistic spectrum disorder (ASD). J Neuroimaging 2004;14:8—15.

Courchesne E. , Karns CM , Davis HR , et al: Unusual brain growth patterns in early life in patients with autistic disorder. Neurology 2001;57:245—254.

Aylward EH , Minshew NJ , Field K. , et al: Effects of age on brain volume and head circumference in autism . Neurology 2002;59:175—183.

Perry EK , Lee ML , Martin-Ruiz CM , et al: Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry 2001;156:1058—1066.

Perry EK , Perry RH : Neurochemistry of consciousness: Cholinergic pathologies in the human brain .Prog Brain Res 2004;145:287—299.

Nelson KB , Grether JK , Croen LA , et al: Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 2001;57:245—254.

Bauman ML , Kemper TL : Neuro-anatomic observations of the brain in autism, in Bauman ML , Kemper TL (eds): The Neurobi- ology of Autism. Baltimore, Johns Hopkins University Press, 1994, 119—145.

Martin-Ruiz CM , Lee M. , Perry PH , et al: Molecular analysis of nicotinic receptor expression of autism. Brain Res Mol Brain Res 2004;123:81—90.

Lee M. , Martin-Ruiz C. , Graham A. , et al: Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 2002;125: 1483—1495.

10.

Hardy J. , Selkoe DJ : The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. S c i e n c e 2002;297:353—356.

11.

Lahiri DK , Farlow MR , Sambamurti K. , et al: A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr Drug Targets 2003;4:97—112.

12.

Ge YW , Lahiri DK : Regulation of promoter activity of the APP gene by cytokines and growth factors: Implications in Alzheimer's disease. Ann N Y Acad Sci 2002;973:463—467.

13.

Filipek PA : Autistic spectrum disorders, in Swaiman KF , Ashwal S (eds): Pediatric Neurology. St. Louis, Mosby, 1999, 606—628.

14.

Deutsch SI , Rosse RB , Mastropaolo J. , Chilton M. : Progressive worsening of adaptive functions in Down syndrome may be mediated by the compl exing of soluble a[beta] peptides with the [alpha] 7 nicotinic acetylcholine receptor: Therapeutic implications. Clin Neuropharmacol 2003;26:277—283.

15.

Sokol DK , Dunn DW , Edwards-Brown M. , Feinberg J. : Hydrogen proton magnetic resonance spectroscopy in autism: Preliminary evidence of elevated choline/creatine ratio. J Child Neurol 2002;17:245—249.

16.

Schopler E. , Reichler RR , Renner BR : Childhood Autism Rating Scale (CARS). Los Angeles, Western Psychological Services, 1988.

17.

Lahiri DK , Chen D. , Ge YW , et al: Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. J Pineal Res 2004;36:224—231.

18.

Belcher JD , Bryant CJ , Nguyen J. , et al: Transgenic sickle mice have vascular inflammation. Blood 2003;101:3953—3959.

19.

Jyonouchi H. , Sun S. , Le H. : Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001;120:170—179.

20.

Zhang X. : Cholinergic activity and amyloid precursor protein processing in aging and Alzheimer's disease. Curr Drug Targets CNS Neurol Disord 2004;3:137—152.

21.

Moore GJ : Proton magnetic resonance spectroscopy in pediatric neuroradiology. Pediatr Radiol 1998;28:805—814.

22.

Esler WP , Wolfe MS : A portrait of Alzheimer secretases—New features and familiar faces. Science 2001;293:1449—1454.

23.

Li Y. , Hollingworth P. , Moore P. , et al: Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease. Hum Mutat 2005;25:270—277.

24.

Sutcliffe JS , Han MK , Amin T. , et al: Partial duplication of the APBA2 gene in chromosome 15q13 corresponds to duplicon structures. MC Genomics 2003;4(1):15.